FDA Office Chief Counsel maintains continuity of temporariness
Executive Summary
David Dorsey, a long-time staffer for Sen. Ted Kennedy, D-Mass., is expected to be the Obama Administration's pick for FDA chief counsel (1"The Pink Sheet," Jan. 19, 2009, p. 3). The choice would be one with a bit of continuity; Dorsey worked in the office of FDA's chief counsel before moving to the Hill. In the meantime, though, FDA is opting for continuity of its own during the transition: Deputy Chief Counsel Jeffrey Senger will be reprising his brief 2007 role by serving as acting chief counsel (2"The Pink Sheet," Sept. 10, 2007, p. 12)